• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Special Reports
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Resources
    • About MassDevice
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
    • In-Depth Coverage
    • Latest News
  • Attend DeviceTalks
    • Events
      • DeviceTalks Minnesota – May 4
      • DeviceTalks Boston – May 27–28
      • DeviceTalks West
      • DeviceTalks Tuesdays
    • DeviceTalks Podcast Network
      • DeviceTalks Weekly
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Advertise
  • Subscribe
Home » LivaNova updates on 3T Heater-Cooler infection prevention corrections

LivaNova updates on 3T Heater-Cooler infection prevention corrections

October 22, 2018 By Fink Densford

LivaNova logo

LivaNova (NSDQ:LIVN) this week updated customers on efforts to correct issues with its 3T Heater-Cooler related to patient infections, providing instructions to monitor hydrogen peroxide concentration and information on a design upgrade.

In a medical device correction letter dated October 18, the company sent instructions for monitoring hydrogen peroxide concentration to limit microbial growth, enhancing previous instructions, and informing users of a new vacuum canister and internal sealing design intended to “further mitigate” the risk of airborne transmission on non-tuberculosis mycobacterium.

Last September, a report emerged suggesting that approximately 12 children who underwent cardiac procedures at Children’s Hospital New Orleans earlier in the year were infected with myobacterium previously linked to the 3T systems.

LivaNova said that initial 3T operating instructions laid out disinfection procedures which aimed to keep a total heterotrophic plate count of less than 100 CFU/ml within the water circuit of the device, which does not come into direct contact with the patient. The company said that if hydrogen peroxide concentration in the water circuit drops below 100 ppm, microorganisms could start to grow between bi-weekly disinfection cycles.

The company warned that even though the fluid in the water circuit does not come into contact with patients, users should be “mindful that aerosols are emitted with the 3T is used, primarily during the patient warming phase at the end of a procedure, when water is returned to the tanks.”

LivaNova said that patients could also come into direct contact with water and solution droplets containing water-borne microorganisms, which could lead to cardiovascular infections including endocarditis or other deep-surgical-site infections.

The company said that it observed a decrease of hydrogen peroxide concentration to zero within a day in a “limited number of devices tested after a period of clinical use.” In the devices, LivaNova said it observed a degradation of nickel coating on cooling coils in the tanks which resulted in exposed copper.

LivaNova said it believes that the rapid hydrogen peroxide decrease could be caused by a reaction between the exposed copper and hydrogen peroxide.

Not all devices demonstrated a decrease of hydrogen peroxide below 100 ppm, LivaNova wrote, and the decrease is expected to vary by device dependent upon age, maintenance, local water conditions and other factors.

In its updated instructions, the company said that users should monitor hydrogen peroxide concentration in the water solution on a daily basis, and that a drop in the concentration over a week-long period is expected, but that the concentration should be maintained at above 100 ppm.

The company also said it developed a new vacuum canister and internal sealing design to reduce airborne transmission risk from 3T devices. It added that it will provide instructions for use when the systems are upgraded, and that users would be contacted by a company agent for the upgrade.

The issues and updates affect 120V, 127V, 200V, 208V, 230V and 240V devices with product code 16-02-80, 16-02-81, 16-02-82, 16-02-83, 16-02-85 and 16-02-95 and a number of different serial number ranges.

Filed Under: Cardiovascular, Featured, Surgical Tagged With: LivaNova

More recent news

  • FDA warns of Philips ultrasound issues after four patient deaths
  • FDA approves Gore bridging stent graft in complex aortic aneurysms
  • Steris inks $2.1B deal for operating room supplier Xodus Medical
  • Insulet’s Omnipod Discover data platform begins full US rollout
  • Siemens Healthineers exits general ultrasound to focus on cardiac imaging

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >
MDO ad
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2026 · Arrowfly LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy